April 17–22, 2026 · San Diego · 2418 items
3 people · 3 posts · 2 abstracts
Sukeshi Patel Arora, Lorena Fuentes, James Denno, Jennifer Moseley, Brittany M. Altermatt, Elizabeth Diaz, Joshua Ray Smith, Joel Michalek, Lei Zheng
Read the abstract →Alberto Giovanni Leone, Alessandra Raimondi, Paolo Manca, Sabina Murgioni, Giovanni G. Cardellino, Alessandro Bittoni, Antonia Strippoli, Maria Bencivenga, Federica Palermo, Floriana Nappo, Silvio K. Garattini, Thereasa Rich, Gaia Rebecchi, Roberta Fazio, Camilla Damonte, Margherita Ambrosini, Cecilia Villa, Greta Gronchi, Sara Lonardi, Filippo Pietrantonio
Read the abstract →VJOncology has released a podcast for Liver Cancer Awareness Month in which several experts discuss advances in the treatment of advanced hepatocellular carcinoma and hepatobiliary tumors. Ghassan Abou-Alfa presents the phase 3 EMERALD-3 trial.
Why it matters: The podcast gives PFS and OS figures for STRIDE plus TACE versus TACE in the phase 3 EMERALD-3 trial, offering a concrete comparison for the intermediate-stage HCC setting.
Final Clinical Trials Plenary, 'Advances in Immunotherapy', chaired by Ryan Sullivan (Massachusetts General Hospital). Alberto Giovanni Leone (Istituto Nazionale dei Tumori) presented phase II INFINITY data on tremelimumab plus durvalumab for organ preservation in MSI-high tumours.